← FDA Drug Approvals (Drugs@FDA)

METHYLPREDNISOLONE SODIUM SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2011-07-18

Drug application

FDA Application #

ANDA040888

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLPREDNISOLONE SODIUM SUCCINATE

Generic name

Methylprednisolone Sodium Succinate

Active ingredients

METHYLPREDNISOLONE SODIUM SUCCINATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

First approval

2011-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown